Shanghai Biotecan Pharmaceuticals Co.
Latest round
- Series A
Last raised
- May 2015
Total raised
- Undisclosed
Investors
- 1
About Shanghai Biotecan Pharmaceuticals Co.
Established in 2008 and based in Shanghai, China, Shanghai Biotecan Pharmaceuticals Co. Ltd. operates as a tumour diagnosis service provider dedicated to providing tumour detection services. It has nineteen subsidiaries. The company acquired CAP (College of American Pathologists) interlaboratory quality assessment and domestic clinical gene amplification laboratory certification (PCR laboratory certification). Biotecan has obtained 32 patents, 29 trademarks and 86 software copyrights. In 2016, Shanghai Biotecan Pharmaceuticals Co. Ltd. was listed on the National Equities Exchange and Quotations. The company mainly provides medical services, which include individualized cancer plans, maternal and child health plans, chronic disease management, infectious disease detection, intestinal microecology. Individualized cancer solutions include genetic testing and solutions for colorectal cancer, lung cancer, breast cancer and other cancers. Shanghai Biotecan Pharmaceuticals Co. Ltd. also provides precision medicine services, which is a medical model that uses modern genetic technology, molecular imaging technology, biological information technology, combined with the patient's living environment and clinical data, to achieve accurate disease classification and diagnosis, and to develop personalized preventive treatment plans.47 million.
Who invested in Shanghai Biotecan Pharmaceuticals Co.
1 investor across 1 round
See all investors in Shanghai Biotecan Pharmaceuticals Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 26, 2015
Amount
Undisclosed
Investors
Questions about Shanghai Biotecan Pharmaceuticals Co.
Who invested in Shanghai Biotecan Pharmaceuticals Co.?
Shanghai Biotecan Pharmaceuticals Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Biotecan Pharmaceuticals Co. raised?
Shanghai Biotecan Pharmaceuticals Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanghai Biotecan Pharmaceuticals Co. last raise money?
Shanghai Biotecan Pharmaceuticals Co.'s most recent round on record is a Series A, in May 2015.
What does Shanghai Biotecan Pharmaceuticals Co. do?
Established in 2008 and based in Shanghai, China, Shanghai Biotecan Pharmaceuticals Co.
Where is Shanghai Biotecan Pharmaceuticals Co. headquartered?
Shanghai Biotecan Pharmaceuticals Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Biotecan Pharmaceuticals Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Shanghai Biotecan Pharmaceuticals Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Shanghai Biotecan Pharmaceuticals Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.